Sirona Biochem Corp.

Sirona Biochem Corp. (http://www.sironabiochem.com/) is a Canada-based cosmetic ingredient and drug discovery company. The Company developed its technology platform at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. Its principal activities are dedicated to the development of cosmetic and pharmaceutical active ingredients which are partners in exchange for payments. The Company’s marketed products include SGLT2 Inhibitor, TFC-1067 and Anti-Aging/ Anti-Wrinkle. SGLT2 Inhibitors is a therapy for diabetes treatments. SGLT2 Inhibitors act in the kidneys to reduce the re-absorption of glucose into the bloodstream. The Company has developed an ingredient, TFC-1067 for the treatment of Dyschromia. The Company through its subsidiary, TFChem, has developed Anti-Aging/ Anti-Wrinkle. The Company through its platform technology, produce therapies in three antiviral categories, Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars.

• Sirona Biochem Corp.